La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Quest Diagnostics Gestion
Gestion contrôle des critères 4/4
Le PDG Quest Diagnostics' est Jim Davis, nommé en Nov2022, a un mandat de 1.75 ans. La rémunération annuelle totale est $ 12.67M, composée du salaire de 9.3% et des bonus 90.7%, y compris les actions et options de la société. détient directement 0.067% des actions de la société, d'une valeur de $ 11.31M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.7 ans et 5 ans.
Informations clés
Jim Davis
Directeur général
US$12.7m
Rémunération totale
| Pourcentage du salaire du PDG | 9.3% |
| Durée du mandat du directeur général | 1.8yrs |
| Propriété du PDG | 0.07% |
| Durée moyenne d'occupation des postes de direction | 3.7yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 5yrs |
Mises à jour récentes de la gestion
Recent updates
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?
Aug 12
Quest Diagnostics: Beat Down After Beating Q2 Estimates
Jul 28The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)
Jul 12Quest Diagnostics: On A Quest For Growth
Jul 12Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns
May 14Quest Diagnostics: Let's Keep Waiting
May 08Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts
Apr 26We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt
Apr 23Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares
Apr 02Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year
Mar 15Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75
Feb 06Quest Diagnostics: Post-COVID Normalization Pretty Much Done
Feb 05Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 11Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price
Dec 24Quest Diagnostics: Market Overreaction Creates Investment Opportunity
Dec 08Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?
Dec 06Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall
Nov 18Quest Diagnostics: Moving Past Covid
Oct 25Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly
Sep 25What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Sep 04Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues
Aug 15Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
Aug 13Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Jul 11Is Quest Diagnostics (NYSE:DGX) A Risky Investment?
Jun 09Quest Diagnostics: Healthier Diagnosis
May 30Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?
May 24Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward
May 09An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued
Mar 22What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?
Feb 19Why Quest Diagnostics Isn't A 'Buy', My Oh My
Feb 14Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's
Feb 05Quest Diagnostics Q4 2022 Earnings Preview
Feb 01Quest Diagnostics' unit Pack Health to expand Alabama facility
Jan 17Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly
Jan 17Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)
Jan 03An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued
Dec 04Quest Diagnostics declares $0.66 dividend
Nov 14Is Now The Time To Look At Buying Quest Diagnostics Incorporated (NYSE:DGX)?
Nov 06Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | US$836m |
| Mar 31 2024 | n/a | n/a | US$842m |
| Dec 31 2023 | US$13m | US$1m | US$850m |
| Sep 30 2023 | n/a | n/a | US$759m |
| Jun 30 2023 | n/a | n/a | US$790m |
| Mar 31 2023 | n/a | n/a | US$789m |
| Dec 31 2022 | US$12m | US$806k | US$942m |
| Sep 30 2022 | n/a | n/a | US$1b |
| Jun 30 2022 | n/a | n/a | US$1b |
| Mar 31 2022 | n/a | n/a | US$2b |
| Dec 31 2021 | US$4m | US$625k | US$2b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$2b |
| Mar 31 2021 | n/a | n/a | US$2b |
| Dec 31 2020 | US$4m | US$577k | US$1b |
| Sep 30 2020 | n/a | n/a | US$1b |
| Jun 30 2020 | n/a | n/a | US$749m |
| Mar 31 2020 | n/a | n/a | US$771m |
| Dec 31 2019 | US$3m | US$590k | US$835m |
| Sep 30 2019 | n/a | n/a | US$709m |
| Jun 30 2019 | n/a | n/a | US$707m |
| Mar 31 2019 | n/a | n/a | US$720m |
| Dec 31 2018 | US$3m | US$590k | US$733m |
| Sep 30 2018 | n/a | n/a | US$860m |
| Jun 30 2018 | n/a | n/a | US$808m |
| Mar 31 2018 | n/a | n/a | US$782m |
| Dec 31 2017 | US$3m | US$590k | US$769m |
Rémunération vs marché: La rémunération totale de Jim ($USD 12.67M ) est dans la moyenne des entreprises de taille similaire sur le marché US ($USD 13.21M ).
Rémunération et revenus: La rémunération de Jim a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Jim Davis (61 yo)
1.8yrs
Titularisation
US$12,673,834
Compensation
Mr. James E. Davis, also known as Jim, serves as Chief Executive Officer and President at Quest Diagnostics Incorporated since November 1, 2022 and serves as its Director since November 2022. He served as...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman | 1.8yrs | US$12.67m | 0.067% $ 11.3m | |
| Executive VP & CFO | 2.1yrs | US$3.98m | 0.016% $ 2.6m | |
| Senior VP & General Counsel | 25yrs | US$2.25m | 0.035% $ 5.8m | |
| Executive Vice President of Regional Businesses | no data | US$3.16m | 0.058% $ 9.8m | |
| Senior Vice President of Clinical Solutions | 2yrs | US$2.02m | 0.014% $ 2.3m | |
| Senior VP | 5.3yrs | pas de données | 0.032% $ 5.4m | |
| Senior VP | less than a year | pas de données | pas de données | |
| Vice President of Investor Relations | no data | pas de données | pas de données | |
| Senior VP & Chief Compliance Officer | 1.8yrs | pas de données | pas de données | |
| Senior VP & Chief Communications Officer | 27.8yrs | pas de données | pas de données | |
| Senior VP & Chief Human Resources Officer | 6.5yrs | pas de données | pas de données | |
| Senior Vice President of Strategy | 8.5yrs | pas de données | pas de données |
3.7yrs
Durée moyenne de l'emploi
61yo
Âge moyen
Gestion expérimentée: L'équipe de direction de DGX est considérée comme expérimentée (ancienneté moyenne 3.7 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chairman | 1.8yrs | US$12.67m | 0.067% $ 11.3m | |
| Independent Director | 10.6yrs | US$315.44k | 0.023% $ 3.8m | |
| Director | less than a year | pas de données | pas de données | |
| Lead Independent Director | 12.7yrs | US$345.94k | pas de données | |
| Independent Director | 19.7yrs | US$342.12k | pas de données | |
| Independent Director | 5.5yrs | US$312.33k | 0.0026% $ 434.0k | |
| Independent Director | 10.1yrs | US$315.73k | 0.016% $ 2.7m | |
| Independent Director | 4.4yrs | US$300.44k | pas de données | |
| Independent Director | 3yrs | US$300.44k | pas de données | |
| Independent Director | 1.3yrs | US$280.41k | pas de données |
5.0yrs
Durée moyenne de l'emploi
65yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de DGX sont considérés comme expérimentés (ancienneté moyenne 5 ans).